Bendazac L-lysine (Bendazaco lisina) is an agent introduced for the management of cataracts, protecting the level of vision in patients, thus delaying the need for surgical intervention.
Molecular Weight:
428.48
Purity:
99.91%
CAS Number:
[81919-14-4]
Formula:
C22H28N4O5
Target:
Others|||Amino Acids and Derivatives
T3141
* VAT and and shipping costs not included. Errors and price changes excepted